{"id":"https://openalex.org/W2993997447","doi":"https://doi.org/10.1038/s41416-019-0628-x","title":"Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells","display_name":"Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells","alternate_titles":[],"publication_year":2019,"publication_date":"2019-12-10","ids":{"openalex":"https://openalex.org/W2993997447","doi":"https://doi.org/10.1038/s41416-019-0628-x","mag":"2993997447","pmid":"https://pubmed.ncbi.nlm.nih.gov/31819183","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6964672"},"language":"en","primary_location":{"id":"doi:10.1038/s41416-019-0628-x","doi":"https://doi.org/10.1038/s41416-019-0628-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41416-019-0628-x","pdf_url":"https://www.nature.com/articles/s41416-019-0628-x.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2993997447"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/s41416-019-0628-x.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027792508","display_name":"Teresa Delgado\u2010Go\u00f1i","orcid":"https://orcid.org/0000-0001-6078-9291","observed_orcids":["https://orcid.org/0000-0001-6078-9291"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Teresa Delgado-Go\u00f1i","raw_affiliation_strings":["Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK. teresa.delgado-goni@psych.ox.ac.uk","Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK. teresa.delgado-goni@psych.ox.ac.uk","Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK"],"raw_orcid":"https://orcid.org/0000-0001-6078-9291","affiliations":[{"raw_affiliation_string":"Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK. teresa.delgado-goni@psych.ox.ac.uk","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I2801316944"]},{"raw_affiliation_string":"Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK. teresa.delgado-goni@psych.ox.ac.uk","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120534135","display_name":"Teresa Casals","orcid":"https://orcid.org/0009-0000-9173-6387","observed_orcids":["https://orcid.org/0009-0000-9173-6387"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Teresa Casals Galobart","raw_affiliation_strings":["Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073545184","display_name":"Slawomir Wantuch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Slawomir Wantuch","raw_affiliation_strings":["Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037507914","display_name":"Deimante Normantaite","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Deimante Normantaite","raw_affiliation_strings":["Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068130659","display_name":"Martin O. Leach","orcid":"https://orcid.org/0000-0002-0756-5368","observed_orcids":["https://orcid.org/0000-0002-0756-5368"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Martin O. Leach","raw_affiliation_strings":["Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK. Martin.Leach@icr.ac.uk","Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK. Martin.Leach@icr.ac.uk","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I2801316944"]},{"raw_affiliation_string":"Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034616567","display_name":"Steven R. Whittaker","orcid":"https://orcid.org/0000-0001-9062-7947","observed_orcids":["https://orcid.org/0000-0001-9062-7947"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven R. Whittaker","raw_affiliation_strings":["Division of Cancer Therapeutics, The Institute of Cancer Research, London, SW7 3RP, UK"],"raw_orcid":"https://orcid.org/0000-0001-9062-7947","affiliations":[{"raw_affiliation_string":"Division of Cancer Therapeutics, The Institute of Cancer Research, London, SW7 3RP, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014075696","display_name":"Mounia Beloueche\u2010Babari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mounia Beloueche-Babari","raw_affiliation_strings":["Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK. mounia.beloueche-babari@icr.ac.uk","Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK. mounia.beloueche-babari@icr.ac.uk","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I2801316944","https://openalex.org/I4210121186"]},{"raw_affiliation_string":"Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I2801316944"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5014075696","https://openalex.org/A5027792508","https://openalex.org/A5068130659"],"corresponding_institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I2801316944","https://openalex.org/I40120149","https://openalex.org/I4210121186"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":{"value":3300,"currency":"USD","value_usd":3300},"fwci":1.2457,"has_fulltext":true,"cited_by_count":44,"citation_normalized_percentile":{"value":0.77499949,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"122","issue":"1","first_page":"72","last_page":"81"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vemurafenib-resistance","display_name":"vemurafenib resistance","score":0.9570000171661377},{"id":"https://openalex.org/keywords/braf-mutant-melanoma","display_name":"BRAF-mutant melanoma","score":0.9480000138282776},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9430000185966492},{"id":"https://openalex.org/keywords/prostaglandin-e2-synthesis","display_name":"prostaglandin E2 synthesis","score":0.8809999823570251},{"id":"https://openalex.org/keywords/prostaglandin-e-synthase","display_name":"prostaglandin E synthase","score":0.6970000267028809},{"id":"https://openalex.org/keywords/pyruvate-carboxylase","display_name":"pyruvate carboxylase","score":0.9470000267028809},{"id":"https://openalex.org/keywords/anaplerotic-metabolism","display_name":"anaplerotic metabolism","score":0.8510000109672546},{"id":"https://openalex.org/keywords/mitochondrial-metabolism","display_name":"mitochondrial metabolism","score":0.9110000133514404},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.7820000052452087},{"id":"https://openalex.org/keywords/glut1","display_name":"GLUT1","score":0.8489999771118164},{"id":"https://openalex.org/keywords/metabolic-vulnerability","display_name":"metabolic vulnerability","score":0.5070000290870667}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.9741700887680054},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6222290992736816},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.597025454044342},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5774844288825989},{"id":"https://openalex.org/C2776470698","wikidata":"https://www.wikidata.org/wiki/Q21851559","display_name":"V600E","level":4,"score":0.4591898024082184},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.36934152245521545},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1827830672264099},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17882630228996277},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000071876","descriptor_name":"Prostaglandin-E Synthases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000077484","descriptor_name":"Vemurafenib","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011766","descriptor_name":"Pyruvate Carboxylase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015232","descriptor_name":"Dinoprostone","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1038/s41416-019-0628-x","doi":"https://doi.org/10.1038/s41416-019-0628-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41416-019-0628-x","pdf_url":"https://www.nature.com/articles/s41416-019-0628-x.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6964672","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6964672/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:31819183","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31819183","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/s41416-019-0628-x","doi":"https://doi.org/10.1038/s41416-019-0628-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41416-019-0628-x","pdf_url":"https://www.nature.com/articles/s41416-019-0628-x.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1517190324","display_name":null,"funder_award_id":"C1060/A10334","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G5992529369","display_name":null,"funder_award_id":"C1090/A16464","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G6423869622","display_name":"Evaluation of non-invasive metabolic imaging biomarkers for novel RAF/MEK1/2-targeted anti-cancer agents","funder_award_id":"MR/K011057/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2993997447.pdf","grobid_xml":"https://content.openalex.org/works/W2993997447.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W85331343","https://openalex.org/W1163924930","https://openalex.org/W1982393730","https://openalex.org/W1988564036","https://openalex.org/W1995103178","https://openalex.org/W2034769395","https://openalex.org/W2036264501","https://openalex.org/W2041729369","https://openalex.org/W2044565982","https://openalex.org/W2051579681","https://openalex.org/W2053756154","https://openalex.org/W2057883975","https://openalex.org/W2062289724","https://openalex.org/W2065812194","https://openalex.org/W2081295565","https://openalex.org/W2095082648","https://openalex.org/W2100614336","https://openalex.org/W2105660237","https://openalex.org/W2108099675","https://openalex.org/W2110682589","https://openalex.org/W2114843025","https://openalex.org/W2116978375","https://openalex.org/W2117692326","https://openalex.org/W2125594974","https://openalex.org/W2128542677","https://openalex.org/W2131719921","https://openalex.org/W2135138705","https://openalex.org/W2141191122","https://openalex.org/W2149441684","https://openalex.org/W2149639441","https://openalex.org/W2152064969","https://openalex.org/W2155381255","https://openalex.org/W2168711434","https://openalex.org/W2265836483","https://openalex.org/W2395626624","https://openalex.org/W2401574182","https://openalex.org/W2469418432","https://openalex.org/W2481729799","https://openalex.org/W2528493125","https://openalex.org/W2560396365","https://openalex.org/W2563689911","https://openalex.org/W2569342357","https://openalex.org/W2585410541","https://openalex.org/W2587917512","https://openalex.org/W2592030361","https://openalex.org/W2612668330","https://openalex.org/W2758067903","https://openalex.org/W2767190680","https://openalex.org/W2792695542","https://openalex.org/W2803210291","https://openalex.org/W2808347790","https://openalex.org/W2808863372","https://openalex.org/W6684641524","https://openalex.org/W6776482781"],"related_works":["https://openalex.org/W4411417966","https://openalex.org/W2606952720","https://openalex.org/W2480049046","https://openalex.org/W2561705918","https://openalex.org/W7201855107","https://openalex.org/W7053060513","https://openalex.org/W2528493125","https://openalex.org/W2308496907","https://openalex.org/W2950299737"],"abstract_inverted_index":{"BACKGROUND:":[0],"BRAF":[1,170],"inhibitors,":[2],"such":[3],"as":[4],"vemurafenib,":[5],"have":[6],"shown":[7],"efficacy":[8],"in":[9,46,61,110,156,164,178,186],"BRAF-mutant":[10,49,187],"melanoma":[11,51,152],"treatment":[12],"but":[13],"acquired-resistance":[14],"invariably":[15],"develops.":[16],"Unveiling":[17],"the":[18,36],"potential":[19],"vulnerabilities":[20,40],"associated":[21],"with":[22,71,131,151],"vemurafenib":[23,45,99,114,185],"resistance":[24,43,183],"could":[25],"provide":[26],"rational":[27],"strategies":[28],"for":[29,194],"combinatorial":[30,195],"treatment.":[31],"METHODS:":[32],"This":[33],"work":[34],"investigates":[35],"metabolic":[37,55,179],"characteristics":[38],"and":[39,58,63,89,94,107,113,138,158],"of":[41],"acquired":[42,182],"to":[44,98,184],"three":[47],"generated":[48],"human":[50],"cell":[52],"clones,":[53],"analysing":[54],"profiles,":[56],"gene":[57,72,160],"protein":[59,136],"expression":[60,73,137,147,161],"baseline":[62],"nutrient":[64],"withdrawal":[65],"conditions.":[66,143],"Preclinical":[67],"findings":[68],"are":[69],"correlated":[70,150],"analysis":[74],"from":[75],"publicly":[76],"available":[77],"clinical":[78],"datasets.":[79],"RESULTS:":[80],"Two":[81],"vemurafenib-resistant":[82],"clones":[83],"showed":[84,120],"dependency":[85],"on":[86,169],"lipid":[87,106],"metabolism":[88],"increased":[90,126,134],"prostaglandin":[91],"E2":[92],"synthesis":[93],"were":[95,162],"more":[96],"responsive":[97],"under":[100,141],"EGFR":[101,108],"inhibition,":[102],"potentially":[103,189],"implicating":[104],"inflammatory":[105],"signalling":[109],"ERK":[111],"reactivation":[112],"resistance.":[115],"The":[116],"third":[117],"resistant":[118],"clone":[119],"higher":[121],"pyruvate-carboxylase":[122],"(PC)":[123],"activity":[124],"indicating":[125],"anaplerotic":[127],"mitochondrial":[128],"metabolism,":[129],"concomitant":[130],"reduced":[132],"GLUT-1,":[133],"PC":[135,157],"survival":[139],"advantage":[140],"nutrient-depleted":[142],"Prostaglandin":[144],"synthase":[145],"(PTGES)":[146],"was":[148],"inversely":[149],"patient":[153],"survival.":[154],"Increases":[155],"PTGES":[159],"observed":[163],"some":[165],"patients":[166],"following":[167],"progression":[168],"inhibitors.":[171],"CONCLUSIONS:":[172],"Altogether,":[173],"our":[174],"data":[175],"highlight":[176],"heterogeneity":[177],"adaptations":[180],"during":[181],"melanoma,":[188],"uncovering":[190],"key":[191],"clinically-relevant":[192],"mechanisms":[193],"therapeutic":[196],"targeting.":[197]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2993997447","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2019-12-13T00:00:00"}
